CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-09-06 | Brandt Peter C. Director | Purchase | +5,300 | $0.95 | $5K | 11,000 |
| 2011-09-06 | Brandt Peter C. Director | Purchase | +3,900 | $0.95 | $4K | 14,900 |
| 2011-09-06 | Brandt Peter C. Director | Purchase | +300 | $0.94 | $283 | 15,200 |
| 2011-09-06 | Brandt Peter C. Director | Purchase | +4,500 | $0.95 | $4K | 19,700 |
| 2011-09-06 | Brandt Peter C. Director | Purchase | +300 | $0.95 | $284 | 20,000 |
| 2011-06-06 | Beever Charles Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2011-06-06 | Brandt Peter C. Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2011-06-06 | McIntosh David M Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2011-06-06 | Cheong Kwang Soo Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2011-06-06 | Kivel Richard Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2011-05-18 | Ahn Chang Ho Chairman & CEO | Purchase | +1,008,078 | $1.31 | $1.3M | 11,338,924 |
| 2011-04-01 | Ahn Chang Ho Chairman & CEO | Purchase | +320,846 | $1.22 | $391K | 10,330,846 |
| 2010-12-14 | Ahn Chang Ho Chairman & CEO | Gift | −300,000 | 10,220,000 | ||
| 2010-12-14 | Ahn Chang Ho Chairman & CEO | Gift | −210,000 | 10,010,000 | ||
| 2010-09-17 | Kivel Richard Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2010-09-17 | Brandt Peter C. Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 | ||
| 2010-06-14 | McIntosh David M Director | Grant or award · Stock Options (right-to-buy) | +20,000 | 20,000 |
Page 22 of 22 · 437 trades